Annamaria Vezzani
#128,675
Most Influential Person Now
Researcher
Annamaria Vezzani's AcademicInfluence.com Rankings
Annamaria Vezzanicomputer-science Degrees
Computer Science
#5546
World Rank
#5856
Historical Rank
Data Mining
#105
World Rank
#105
Historical Rank
Machine Learning
#1515
World Rank
#1537
Historical Rank
Artificial Intelligence
#1750
World Rank
#1782
Historical Rank
Download Badge
Computer Science
Annamaria Vezzani's Degrees
- PhD Computer Science University of Milan
- Masters Computer Engineering University of Bologna
- Bachelors Computer Engineering University of Bologna
Similar Degrees You Can Earn
Why Is Annamaria Vezzani Influential?
(Suggest an Edit or Addition)Annamaria Vezzani's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The role of inflammation in epilepsy (2011) (1402)
- The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission 1 (2011) (1387)
- Brain Inflammation in Epilepsy: Experimental and Clinical Evidence (2005) (960)
- Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures (2010) (787)
- Interleukin-1β Enhances NMDA Receptor-Mediated Intracellular Calcium Increase through Activation of the Src Family of Kinases (2003) (774)
- Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain (2004) (668)
- Glia and epilepsy: excitability and inflammation (2013) (612)
- Innate and adaptive immunity during epileptogenesis and spontaneous seizures: Evidence from experimental models and human temporal lobe epilepsy (2008) (611)
- Interleukin-1β Immunoreactivity and Microglia Are Enhanced in the Rat Hippocampus by Focal Kainate Application: Functional Evidence for Enhancement of Electrographic Seizures (1999) (573)
- Epilepsy and brain inflammation (2013) (499)
- The role of cytokines in the pathophysiology of epilepsy (2008) (496)
- Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus (2000) (496)
- Neuropeptide Y: emerging evidence for a functional role in seizure modulation (1999) (456)
- Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. (2000) (451)
- Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability (2015) (442)
- Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid (1984) (402)
- The role of inflammation in epileptogenesis (2013) (388)
- Interleukin‐1β contributes to the generation of experimental febrile seizures (2005) (386)
- Functional Role of Inflammatory Cytokines and Antiinflammatory Molecules in Seizures and Epileptogenesis (2002) (380)
- Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy (2019) (349)
- Epilepsy (2018) (340)
- IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures (2011) (329)
- Infections, inflammation and epilepsy (2016) (301)
- Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice (2011) (262)
- A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. (2008) (256)
- Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study (2018) (256)
- Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development (2003) (253)
- Epileptogenesis Provoked by Prolonged Experimental Febrile Seizures: Mechanisms and Biomarkers (2010) (246)
- Advances in the development of biomarkers for epilepsy (2016) (241)
- Limbic Seizures Induce P-Glycoprotein in Rodent Brain: Functional Implications for Pharmacoresistance (2002) (236)
- The IL-1β system in epilepsy-associated malformations of cortical development (2006) (235)
- Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus (2004) (229)
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options (2020) (227)
- Seizure‐induced brain‐borne inflammation sustains seizure recurrence and blood–brain barrier damage (2012) (223)
- New Roles for Interleukin-1 Beta in the Mechanisms of Epilepsy (2007) (218)
- Inhibition of the Multidrug Transporter P‐Glycoprotein Improves Seizure Control in Phenytoin‐treated Chronic Epileptic Rats (2006) (214)
- Modulator Effects of Interleukin-1β and Tumor Necrosis Factor-α on AMPA-Induced Excitotoxicity in Mouse Organotypic Hippocampal Slice Cultures (2005) (210)
- Epilepsy biomarkers (2013) (200)
- Glia as a source of cytokines: Implications for neuronal excitability and survival (2008) (198)
- Albumin induces excitatory synaptogenesis through astrocytic TGF-β/ALK5 signaling in a model of acquired epilepsy following blood–brain barrier dysfunction (2015) (193)
- Brain inflammation as a biomarker in epilepsy. (2011) (191)
- Febrile infection‐related epilepsy syndrome treated with anakinra (2016) (185)
- Inflammation and prevention of epileptogenesis (2011) (184)
- Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system (2006) (183)
- Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development. (2011) (180)
- Astrocyte immune responses in epilepsy (2012) (180)
- Acute encephalopathy with inflammation-mediated status epilepticus (2011) (179)
- Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1β production (2008) (175)
- Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors (2003) (174)
- Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. (1989) (174)
- Tumor necrosis factor‐α inhibits seizures in mice via p75 receptors (2005) (170)
- Inactivation of Caspase‐1 in Rodent Brain: A Novel Anticonvulsive Strategy (2006) (169)
- Commonalities in epileptogenic processes from different acute brain insults: Do they translate? (2018) (168)
- Inflammatory Response and Glia Activation in Developing Rat Hippocampus after Status Epilepticus (2005) (166)
- Interleukin‐1 type 1 receptor/Toll‐like receptor signalling in epilepsy: the importance of IL‐1beta and high‐mobility group box 1 (2011) (166)
- Epilepsy and Inflammation in the Brain: Overview and Pathophysiology (2014) (164)
- Immunity and Inflammation in Epilepsy. (2016) (163)
- High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products (2011) (161)
- Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy (1995) (158)
- Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? (2004) (156)
- Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy (2013) (154)
- Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. (2008) (154)
- Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies (2018) (149)
- Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis (1999) (148)
- Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures (2013) (147)
- Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis (1996) (141)
- Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. (2014) (137)
- Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy (2017) (136)
- Significance of MDR1 and multiple drug resistance in refractory human epileptic brain (2004) (132)
- Neuroinflammatory targets and treatments for epilepsy validated in experimental models (2017) (125)
- The anti‐epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors (2005) (125)
- GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis (2015) (119)
- Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy (2019) (118)
- In Vivo Brain Dialysis of Amino Acids and Simultaneous EEG Measurements Following Intrahippocampal Quinolinic Acid Injection: Evidence for a Dissociation Between Neurochemical Changes and Seizures (1985) (114)
- Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis (2006) (113)
- Interleukin‐1 System in CNS Stress (2007) (112)
- Blood–brain barrier dysfunction–induced inflammatory signaling in brain pathology and epileptogenesis (2012) (112)
- Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: temporal evolution of changes as compared to neuropeptide Y (1999) (111)
- Inflammation and epilepsy. (2012) (109)
- Recombinant AAV‐mediated expression of galanin in rat hippocampus suppresses seizure development (2003) (107)
- ICE/caspase 1 inhibitors and IL-1beta receptor antagonists as potential therapeutics in epilepsy. (2010) (105)
- Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy. (2019) (103)
- Determination of Endogenous Acetylcholine Release in Freely Moving Rats by Transstriatal Dialysis Coupled to a Radioenzymatic Assay: Effect of Drugs (1987) (103)
- Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y (2002) (101)
- Inflammation and reactive oxygen species as disease modifiers in epilepsy (2020) (100)
- Tumor necrosis factor-alpha inhibits seizures in mice via p75 receptors. (2005) (98)
- IL-1β is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence (2011) (97)
- Febrile Infection–Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis (2016) (96)
- Age-dependent vascular changes induced by status epilepticus in rat forebrain: Implications for epileptogenesis (2009) (96)
- Long‐lasting pro‐ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology (2012) (94)
- Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity (2011) (88)
- Modulation of neuronal excitability by immune mediators in epilepsy. (2016) (86)
- Inflammation and Epilepsy (2005) (86)
- Antiepileptic Effects of Botulinum Neurotoxin E (2005) (85)
- Altered expression of GABAa and GABAb receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus (2005) (84)
- Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration (2001) (84)
- Anticonvulsant properties of BIBP3226, a non‐peptide selective antagonist at neuropeptide Y Y1 receptors (1998) (83)
- Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor‐mediated IL‐1β release (2008) (82)
- Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application (2015) (82)
- Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice (2002) (80)
- Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. (1986) (79)
- Distinct Changes in Peptide YY Binding to, and mRNA Levels of, Y1 and Y2 Receptors in the Rat Hippocampus Associated with Kindling Epileptogenesis (1998) (77)
- Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. (1994) (77)
- A Pilot Study on Brain‐to‐Plasma Partition of 10,11‐Dyhydro‐10‐hydroxy‐5H‐dibenzo(b,f)azepine‐5‐carboxamide and MDR1 Brain Expression in Epilepsy Patients Not Responding to Oxcarbazepine (2005) (77)
- In vivo imaging of glia activation using 1H‐magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity (2012) (76)
- Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood–brain barrier permeability (2008) (75)
- High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy (2017) (75)
- White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA Epilepsy study (2019) (74)
- Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection–related epilepsy syndrome (2019) (73)
- Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: Implications for seizure susceptibility (2009) (72)
- Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy (2017) (71)
- Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures (1996) (71)
- Role of the N-methyl-d-aspartate-type receptors in the development and maintenance of hippocampal kindling in rats (1988) (71)
- Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation. (2017) (69)
- Current understanding and neurobiology of epileptic encephalopathies (2016) (69)
- Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats (1994) (69)
- A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201–995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus (1991) (68)
- Functional effects of d-Phe-c[Cys-Tyr-d-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats (1995) (68)
- Electrical Kindling of the Hippocampus is Associated with Functional Activation of Neuropeptide Y‐containing Neurons (1993) (67)
- Increased Expression of GAP‐43, Somatostatin and Neuropeptide Y mRNA in the Hippocampus During Development of Hippocampal Kindling in Rats (1993) (66)
- The dual role of TNF-α and its receptors in seizures (2013) (66)
- Selective and persistent upregulation of mdr1b mRNA and P-glycoprotein in the parahippocampal cortex of chronic epileptic rats (2004) (64)
- Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis? (2015) (63)
- Gene therapy in epilepsy: The focus on NPY (2007) (63)
- n-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis (2018) (62)
- Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures (1996) (62)
- Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy (2019) (62)
- Does brain inflammation mediate pathological outcomes in epilepsy? (2014) (60)
- In vivo and in vitro studies on the regulation of cholinergic neurotransmission in striatum, hippocampus and cortex of aged rats (1986) (59)
- Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies (2018) (59)
- Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus (2010) (59)
- NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning (2008) (57)
- Stimulation of 5‐HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats (1996) (56)
- Neuroprotective Effect of Somatostatin on Nonapoptotic NMDA‐Induced Neuronal Death: Role of Cyclic GMP (1997) (56)
- Cognitive deficits and brain myo-Inositol are early biomarkers of epileptogenesis in a rat model of epilepsy (2016) (56)
- Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development (2006) (55)
- Glia-neuronal interactions in ictogenesis and epileptogenesis: role of inflammatory mediators (2012) (53)
- Plastic Changes in Neuropeptide Y Receptor Subtypes in Experimental Models of Limbic Seizures (2000) (53)
- Effect of various calcium channel blockers on three different models of limbic seizures in rats (1988) (53)
- Proteomic profiling of epileptogenesis in a rat model: Focus on inflammation (2016) (52)
- [3H]Norepinephrine Release from Hippocampal Slices Is an In Vitro Biochemical Tool for Investigating the Pharmacological Properties of Excitatory Amino Acid Receptors (1987) (51)
- Anti-somatostatin antibody enhances the rate of hippocampal kindling in rats (1993) (51)
- Therapeutic potential of new antiinflammatory drugs (2011) (50)
- Finding a better drug for epilepsy: Antiinflammatory targets (2012) (49)
- Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. (2005) (49)
- Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats (1992) (49)
- Functional role of proinflammatory and anti-inflammatory cytokines in seizures. (2004) (48)
- Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia. (2011) (47)
- Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons (1991) (47)
- Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence (2018) (45)
- Electrocorticographic Dynamics as a Novel Biomarker in Five Models of Epileptogenesis (2017) (44)
- The pivotal role of immunity and inflammatory processes in epilepsy is increasingly recognized: introduction. (2011) (43)
- Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors. (2000) (42)
- Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments. (1986) (42)
- Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? (2020) (41)
- Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis. (1991) (39)
- Alternative Splicing at the C‐terminal but not at the N‐terminal Domain of the NMDA Receptor NR1 is Altered in the Kindled Hippocampus (1995) (39)
- Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder (2002) (39)
- Inhibition of monoacylglycerol lipase terminates diazepam‐resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet (2018) (37)
- Increased preproneuropeptide Y mRNA in the rat hippocampus during the development of hippocampal kindling: Comparison with the expression of preprosomatostatin mRNA (1991) (37)
- Preventing epileptogenesis: A realistic goal? (2016) (37)
- Neuropeptide Y overexpression using recombinant adenoassociated viral vectors (2009) (36)
- Neuroinflammation Alters Integrative Properties of Rat Hippocampal Pyramidal Cells (2018) (33)
- Activation of toll-like receptor , RAGE and HMGB 1 signalling in malformations of cortical development (2011) (33)
- The ENIGMA‐Epilepsy working group: Mapping disease from large data sets (2020) (32)
- Extracellular Somatostatin Measured by Microdialysis in the Hippocampus of Freely Moving Rats: Evidence for Neuronal Release (1993) (32)
- Trans‐synaptic Modulation of Striatal ACh Release In Vivo by the Parafascicular Thalamic Nucleus (1995) (32)
- The immunoproteasome β5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy (2015) (30)
- Pilocarpine-Induced Seizures Revisited: What Does the Model Mimic? (2009) (30)
- Mechanisms of Fever and Febrile Seizures: Putative Role of the Interleukin-1 System (2002) (30)
- miR147b: A novel key regulator of interleukin 1 beta‐mediated inflammation in human astrocytes (2018) (30)
- Epileptic Encephalitis: The Role of the Innate and Adaptive Immune System (2012) (28)
- Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt–Jakob Disease (2017) (28)
- Erratum: Interleukin-1β contributes to the generation of experimental febrile seizures (Annals of Neurology (January 2005) 57 (152-155)) (2005) (28)
- Plasticity of somatostatin and somatostatin sst2A receptors in the rat dentate gyrus during kindling epileptogenesis (2004) (28)
- Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate (1995) (28)
- Basic mechanisms of status epilepticus due to infection and inflammation (2009) (27)
- Innate Immunity and Inflammation in Temporal Lobe Epilepsy: New Emphasis on the Role of Complement Activation (2008) (26)
- Before Epilepsy Unfolds: Finding the epileptogenesis switch (2012) (26)
- Common data elements and data management: Remedy to cure underpowered preclinical studies (2017) (25)
- Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes. (1987) (25)
- Autoradiographical analysis of excitatory amino acid binding sites in rat hippocampus during the development of hippocampal kindling (1990) (25)
- The promise of gene therapy for the treatment of epilepsy (2007) (24)
- Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice (1999) (24)
- Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis (1996) (23)
- Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats (2005) (23)
- Chronic infusion of quinolinic acid in rat striatum: effects on discrete neuronal populations (1992) (22)
- Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions (2017) (20)
- Functional activation of somatostatin- and neuropeptide Y-containing neurons in the entorhinal cortex of chronically epileptic rats (1996) (20)
- Production of quinolinic acid and kynurenic acid by human glioma. (1991) (20)
- Summary Sox 2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain (2004) (19)
- Cellular localization of neuropeptide-Y receptors in the rat hippocampus: long-term effects of limbic seizures. (1996) (19)
- Effect of aspartame on seizures in various models of experimental epilepsy. (1988) (19)
- Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis (1988) (19)
- Proposal to optimize evaluation and treatment of Febrile infection‐related epilepsy syndrome (FIRES): A Report from FIRES workshop (2020) (19)
- Neuronal hyperexcitability and seizures are associated with changes in glial–neuronal interactions in the hippocampus of a mouse model of epilepsy with mental retardation (2010) (18)
- Studies on the Susceptibility to Convulsions in Animals Receiving Abuse Doses of Aspartame (1988) (18)
- In vitro responsiveness of human-drug-resistant tissue to antiepileptic drugs: Insights into the mechanisms of pharmacoresistance (2006) (18)
- Brain Inflammation and Seizures: Evolving Concepts and New Findings in the Last 2 Decades (2020) (18)
- Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages (2021) (17)
- Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop (2021) (16)
- Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability (1989) (16)
- Gene Therapy in Epilepsy (2004) (15)
- Glia–Neuron Interactions in Ictogenesis and Epileptogenesis (2012) (15)
- Basic mechanisms of MCD in animal models. (2009) (15)
- Epileptogenic Activity of Two Peptides Derived from Diazepam Binding Inhibitor After Intrahippocampal Injection in Rats (1991) (15)
- VEGF as a Target for Neuroprotection (2008) (15)
- Lasting Increase in Serotonin 5‐HT1A but Not 5‐HT4 Receptor Subtypes in the Kindled Rat Dentate Gyrus: Dissociation from Local Presynaptic Effects (1998) (15)
- Genetic toxicity of a mixture of fifteen pesticides commonly found in the Italian diet (1993) (15)
- Electrical kindling is associated with a lasting increase in the extracellular levels of kynurenic acid in the rat hippocampus (1995) (14)
- A noradrenergic component of quinolinic acid-induced seizures (1985) (14)
- Neurodegenerative Effects Induced by Chronic Infusion of Quinolinic Acid in Rat Striatum and Hippocampus (1991) (14)
- Kynurenic acid synthesis by human glioma (1990) (14)
- Growth‐associated Protein 43 Expression in Hippocampal Molecular Layer of Chronic Epileptic Rats Treated with Cycloheximide (2005) (14)
- 2014 Epilepsy Benchmarks Area II: Prevent Epilepsy and Its Progression (2016) (14)
- Functional activation of somatostatin and neuropeptide Y containing neurons in experimental models of limbic seizures. (1996) (13)
- Astrocytes in the initiation and progression of epilepsy (2022) (13)
- Epilepsy and brain in fl ammation (2013) (13)
- The association between systemic autoimmune disorders and epilepsy and its clinical implications. (2020) (12)
- Climate change and epilepsy: Insights from clinical and basic science studies (2021) (12)
- A systems-level analysis highlights microglial activation as a modifying factor in common forms of human epilepsy (2018) (12)
- Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model (2018) (12)
- Brain Inflammation and Epilepsy (2010) (12)
- TLR3 preconditioning induces anti-inflammatory and anti-ictogenic effects in mice mediated by the IRF3/IFN-β axis (2019) (12)
- Autoradiographic Reevaluation of the Binding Properties of 125I‐[Leu31,Pro34]Peptide YY and 125I‐Peptide YY3‐36 to Neuropeptide Y Receptor Subtypes in Rat Forebrain (1999) (11)
- Immunity Activation in Brain Cells in Epilepsy: Mechanistic Insights and Pathological Consequences (2013) (11)
- A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies (2021) (10)
- Brain Inflammation and Seizures (2004) (10)
- VEGF and Seizures: Cross-talk between Endothelial and Neuronal Environments (2005) (10)
- Novel Concepts in Epileptogenesis and its Prevention (2014) (10)
- Epigenetic control of epileptogenesis by miR-146a (2017) (10)
- In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery (2021) (9)
- CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy (2021) (9)
- Fetal brain inflammation may prime hyperexcitability and behavioral dysfunction later in life (2013) (9)
- Effects of Interleukin-1 and Tumor Necrosis Factor-on AMPA-Induced Excitotoxicity in Mouse Organotypic Hippocampal Slice Cultures (2005) (9)
- Leukocyte–Endothelial Adhesion Mechanisms in Epilepsy: Cheers and Jeers (2009) (9)
- High‐mobility group box 1 as a predictive biomarker for drug‐resistant epilepsy: A proof‐of‐concept study (2021) (8)
- Time‐ and Region‐Specific Variations in Somatostatin Release Following Amygdala Kindling in the Rat (1998) (8)
- Mode of action of gamma-butyrolactone on the central cholinergic system (1983) (8)
- Changes of dimension of EEG/ECoG nonlinear dynamics predict epileptogenesis and therapy outcomes (2019) (8)
- Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy. (2017) (7)
- Biomarkers in Epilepsy (2016) (7)
- Gene therapy of focal‐onset epilepsy by adeno‐associated virus vector‐mediated overexpression of neuropeptide Y (2010) (7)
- Neurology—the next 10 years (2015) (7)
- Changes in the ADP-ribosylation status of some hippocampal proteins are linked to kindling progression. (1994) (7)
- Regional production of nitric oxide after a peripheral or central low dose of LPS in mice. (1996) (7)
- Effect of dimethylamino-2-ethoxyimino-2-adamantane (CM 54903), a non-polar dimethylaminoethanol analog, on brain regional cholinergic neurochemical parameters. (1982) (6)
- Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy (2021) (6)
- Epileptogenic Role of Astrocyte Dysfunction (2008) (6)
- ATP as a marker of excitotoxin-induced nerve cell death in vivo (2005) (6)
- Inflammation and Immunomodulation in Epilepsy and Its Comorbidities (2015) (6)
- Introduction to the 2nd Meeting on Immunity and Inflammation in Epilepsy (IIE2016) (2017) (5)
- Glia–neuron interactions in epilepsy: Inflammatory mediators (2010) (5)
- Changes in pre- and postsynaptic components of noradrenergic transmission in hippocampal kindling in rats (1991) (5)
- Editorial: Experimental Models of Epilepsy and Related Comorbidities (2019) (4)
- Development of In Vivo Imaging Tools for Investigating Astrocyte Activation in Epileptogenesis (2017) (4)
- Quinolinate And Kynurenate, Two Endogenous Tryptophan Metabolites With Potential Links To Epileptic Disorders (1984) (4)
- Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551. (1994) (4)
- 2 . 3 Activation of TLR , RAGE and HMGB 1 signaling in malformations of cortical development (2013) (4)
- Introduction (2011) (4)
- The Toll Receptor Family: From Microbial Recognition to Seizures (2006) (3)
- GABAA receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β (2022) (3)
- General conclusions (2002) (3)
- Lipid mediator n‐3 docosapentaenoic acid‐derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G‐protein‐coupled receptor (2021) (3)
- [New developments in epileptogenesis and therapeutic perspectives]. (2011) (2)
- Targeting Oxidative Stress with Antioxidant Duotherapy after Experimental Traumatic Brain Injury (2021) (2)
- Neuropeptide Y and Y1 Receptors in Kindling Epileptogenesis (2004) (2)
- Immune Responses in the CNS in Epilepsy (2014) (2)
- Neuroimmunology of status epilepticus (2023) (2)
- Glutamate and Glutamine in the Brain Modulatory Role of Neuropeptides in Seizures Induced in Rats by Stimulation of Glutamate Receptors 1 (2000) (2)
- Somatostatin-and Neuropeptide Y-Mediated Neurotransmission in Kindling Epileptogenesis (1998) (2)
- Theta rhythm alterations – a novel predictive biomarker of epilepsy (2017) (2)
- WONOEP XI: Workshop summary by the Scientific Organizing Committee (2012) (2)
- Tissue Plasminogen Activator, Neuroserpin, and Seizures (2005) (2)
- Interleukin-1 beta enhances NMDA receptor-mediated [Ca2+](1) increase in primary rat hippocampal neurons: Role in neurotoxicity. (2003) (1)
- A phenomenological model of neuroimmune interactions in epileptogenesis (2021) (1)
- Symposia (2015) (1)
- Intrinsic Inflammation Is a Potential Anti-Epileptogenic Target in the Organotypic Hippocampal Slice Model (2018) (1)
- Emerging Molecular Mechanisms of Neuroinflammation in Seizure Disorders (2021) (1)
- Chromosome 14 deletions, rings, and epilepsy genes: A riddle wrapped in a mystery inside an enigma (2020) (1)
- Neuroinflammation microenvironment sharpens seizure circuit (2023) (1)
- Highlights of the basic science sessions at the 27th International Epilepsy Congress (Singapore, July 8–12, 2007) (2008) (1)
- Taking action on climate change: Testimonials and position statement from the International League Against Epilepsy Climate Change Commission (2023) (1)
- Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy (2022) (1)
- A mathematical model of neuroimmune interactions in epileptogenesis for discovering treatment strategies (2022) (1)
- Biochemical and functional studies on noradrenergic and peptidergic neurotransmission in hippocampal kindling. (1992) (1)
- Brain Autonomous Mechanisms of Seizure-Induced BBB Dysfunction (2012) (1)
- Table 1, Anticonvulsant effects of NPY injected in rodent models of seizures (2012) (0)
- Distribution and function of central somatostatin (SRIF) receptors (1995) (0)
- Faculty of 1000 evaluation for High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway. (2018) (0)
- IN40-WE-02 Role of inflammation in focal adult onset epilepsy (2009) (0)
- Third Conference on Epileptogenesis S Servolo Island, Venice, Italy July 27‐30, 2005 (2006) (0)
- The role of reflex control of immunity in the anticonvulsive effects of vagus nerve stimulation (2014) (0)
- S.24.03 Neuropeptides and epilepsy (2004) (0)
- Development of In Vivo Imaging Tools for Investigating Astrocyte Activation in Epileptogenesis (2017) (0)
- UvA-DARE ( Digital Academic Repository ) Inflammation and epilepsy : the contribution of astrocytes (2013) (0)
- Stimulation of [3H]norepinephrine release from hippocampal slices by excitatory amino acids. (1989) (0)
- The effect of IL-1B and specific ice/caspase-1 bloker on spike-and-wave discharges (2011) (0)
- Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (0)
- Cytokine-mediated cross-talk between glia and neurons: neuropathological implications for epilepsy (2009) (0)
- Neuropathology of New-Onset Refractory Status Epilepticus (NORSE). (2023) (0)
- A5 REDUCED ATTENTION AND INCREASED IMPULSIVITY IN MICE LACKING NPY-Y2 RECEPTORS (2005) (0)
- 8-hydroxydipropyl-amino-tetralin inhibits EEG seizure activity induced by intrahippocampal injection of Kainic acid in rats (1995) (0)
- Figure 2, Inflammatory processes in the hippocampus of epileptic mice (2012) (0)
- Review and standard operating procedures for collection of biospecimens and analysis of biomarkers in new onset refractory status epilepticus. (2023) (0)
- Subject Index Vol. 3,1996 (1996) (0)
- Ictogenic and Epileptogenic Mechanisms of Neuroinflammation: Insights From Animal Models (2018) (0)
- Interleukin-1EnhancesNMDAReceptor-Mediated IntracellularCalciumIncreasethroughActivationoftheSrc FamilyofKinases (2003) (0)
- A ROLE FOR TOLL-LIKE RECEPTOR 4 (TLR4) ACTIVATION BY THE HIGH MOBILITY GROUP BOX 1 (HMGB1) PROTEIN IN ICTOGENESIS (2009) (0)
- Inflammation: Inflammatory Responses and Cytokines (2009) (0)
- In vivo genotoxicity of the pesticide Linuron (1992) (0)
- In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery (2021) (0)
- Interleukin-1type1receptor⁄Toll-likereceptorsignallingin epilepsy:theimportanceofIL-1betaandhigh-mobilitygroup box1 (2011) (0)
- Neuroinflammation Alters Integrative Properties of Rat Hippocampal Pyramidal Cells (2018) (0)
- White matter abnormalities across different epilepsy syndromes in adults : an ENIGMA Epilepsy study Short Title : White matter across epilepsy syndromes (2020) (0)
- Faculty Opinions recommendation of Reactive astrogliosis causes the development of spontaneous seizures. (2015) (0)
- A team science approach for the preclinical and clinical characterization and biomarker development for post‐traumatic epilepsy ( PTE ) (2023) (0)
- Changes in pre- and postsynaptic serotonin transmission in kindled rat hippocampus (1995) (0)
- Neuropeptide Ygene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy (2008) (0)
- Table 2, Effects of rAAV-NPY vector injection in rat models of seizures and epilepsy (2012) (0)
- Faculty Opinions recommendation of Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis. (2017) (0)
- SÖZEL B‹LD‹R‹LER / ORAL PRESENTATIONS (2009) (0)
- A Mathematical Model of Neuroimmune Interactions in Epileptogenesis: A New Tool for Discovering Treatment Strategies In Silico (2021) (0)
- Novel Concepts in Epileptogenesis and its Prevention (2014) (0)
- An in vitro model of drug-resistant seizures for selecting clinically effective antiseizure medications in Febrile Infection-Related Epilepsy Syndrome (2023) (0)
- Abstracts of the 6th Meeting of the Neapolitan Brain Group (2018) (0)
- Venice Conference on Epileptogenesis,¶June 23–26, 1999, S. Servolo-Venezia, Italy (1999) (0)
- Faculty Opinions recommendation of Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. (2019) (0)
- Agonists and Antagonists at Neuropeptide (i.e., Somatostatin and Neuropeptide Y) Receptors in the CNS [1,2] (1997) (0)
- Figure 1, Long-term potentiation is attenuated by rAAV-NPY treatment, but not further compromised in hyperexcitable kindled rats (2012) (0)
- Seizure Propensity and Brain Development: A Lesson from Animal Models (2009) (0)
- Neuropeptide Y receptor binding sites in the rat hippocampus after limbic seizures induced by kainic acid and kindling (1995) (0)
- Differential changes in somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in chronic models of temporal lobe epilepsy (1995) (0)
- Neuropeptides and their receptors in synaptic plasticity and epileptogenesis (1999) (0)
- Febrile Response and Seizures (2019) (0)
- Faculty Opinions recommendation of Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy. (2019) (0)
- Figure 1, Inflammatory processes in chronic epilepsy patients: focal epilepsy (2012) (0)
- Notice of retraction: Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy (Brain (2017) 140, (1885–1899) DOI:10.1093/Brain/awx117) (2019) (0)
- On Demand Up-regulation of Therapeutic Genes in the Brain: Fiction or Reality? (2007) (0)
- Fourth Conference on Epileptogenesis, May 23–26, 2007, Pisa, Italy (2008) (0)
- Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions (2017) (0)
- Characterisation of an infantile rat model of de novo status epilepticus: long-term outcomes (2019) (0)
- DOES BLOCKADE OF THE PROINFLAMMATORY IL-1b/IL-1 RECEPTOR TYPE 1 SIGNALING PREVENT OR MODIFY EPILEPTOGENESIS IN TWO DIFFERENT RAT MODELS OF EPILEPSY? (2013) (0)
- Faculty Opinions recommendation of Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy. (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Annamaria Vezzani?
Annamaria Vezzani is affiliated with the following schools:
